Downs Christopher S — SEC insider filings
SEC reporting owner CIK 1705978. 17 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2020-08-25 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 6 filings — 248,266 shares, $363,670 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 142,000 shares @ $2.04 ($289,680) in CNS Pharmaceuticals, Inc., filed 2020-08-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | Chief Financial Officer | 13 | 6 legs · 248,266 sh · $363,670 | — | 11 |
| EBET, Inc. (EBET) | Director | 2 | — | — | 3 |
| Vertical Data Inc. (VDTA) | Interim CFO and Secretary | 2 | — | — | 3 |
Insider filings — Downs Christopher S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | Vertical Data Inc. (VDTA) | Grant/award (A): 1,270 @ $3.94 | EDGAR |
| 2026-10-02 | 4 | Vertical Data Inc. (VDTA) | Grant/award (A): 1,357 @ $3.68 · Grant/award (A): 891 @ $5.61 | EDGAR |
| 2025-11-19 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 4,881 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 40,000 (derivative) · Grant/award (A): 40,000 (derivative) | EDGAR |
| 2024-02-06 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase (P): 66,666 @ $0.30 · Grant/award (A): 66,666 (derivative) · Grant/award (A): 66,666 (derivative) | EDGAR |
| 2023-08-23 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase (P): 27,000 @ $1.27 | EDGAR |
| 2023-05-01 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Option exercise (M): 521 · Option exercise (M): 521 (derivative) | EDGAR |
| 2023-04-18 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase (P): 3,100 @ $3.20 | EDGAR |
| 2023-03-31 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 6,067 (derivative) | EDGAR |
| 2023-02-10 | 4 | EBET, Inc. (EBET) | Option exercise (M): 6,300 · Option exercise (M): 6,300 (derivative) | EDGAR |
| 2022-04-29 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 250,000 (derivative) | EDGAR |
| 2022-03-14 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 33,000 @ $0.31 | EDGAR |
| 2022-02-11 | 4 | Esports Technologies, Inc. (EBET) | Grant/award (A): 6,300 (derivative) | EDGAR |
| 2021-12-07 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase (P): 5,000 @ $0.94 | EDGAR |
| 2021-11-22 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase (P): 4,500 @ $1.15 | EDGAR |
| 2021-02-09 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 131,000 (derivative) | EDGAR |
| 2020-08-25 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase (P): 142,000 @ $2.04 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1705978 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs